{"id":63149,"date":"2021-03-12T17:59:00","date_gmt":"2021-03-12T20:59:00","guid":{"rendered":"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/"},"modified":"2021-03-12T17:59:00","modified_gmt":"2021-03-12T20:59:00","slug":"anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir","status":"publish","type":"post","link":"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/","title":{"rendered":"Anvisa d\u00e1 registro definitivo \u00e0 vacina de Oxford e autoriza o remdesivir"},"content":{"rendered":"<p style=\"text-align: justify;\">A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) concedeu o registro definitivo para dois f\u00e1rmacos utilizados no combate \u00e0\u00a0<strong>Covid-19<\/strong>. S\u00e3o eles: a vacina de Oxford, j\u00e1 usada em car\u00e1ter emergencial e o medicamento remdesivir, da biofarmac\u00eautica americana Gilead Sciences.<\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\">O antiviral tamb\u00e9m contou com autoriza\u00e7\u00e3o por parte da Food And Drug Administration (FDA), a ag\u00eancia reguladora de sa\u00fade nos Estados Unidos. Agora, no Brasil, ter\u00e1 descrito em bula que \u00e9 um medicamento aprovado para o tratamento da Covid-19 \u2014 algo in\u00e9dito at\u00e9 aqui. A indica\u00e7\u00e3o de uso \u00e9 para pacientes acima de 12 anos com mais de 40 quilos que apresentem pneumonia causada pelo v\u00edrus, necessitando de suplementa\u00e7\u00e3o extra de oxig\u00eanio. O tratamento deve levar entre 5 a 10 dias.<\/p>\n<p style=\"text-align: justify;\">Aqui no Brasil, por defini\u00e7\u00e3o da Anvisa, o nome ser\u00e1 grafado como\u00a0<strong>remdesivir<\/strong>, diferente do original.<\/p>\n<p style=\"text-align: justify;\">Com essa autoriza\u00e7\u00e3o de hoje, a vacina do cons\u00f3rcio AstraZeneca\/Oxford poder\u00e1 ter uma etapa de produ\u00e7\u00e3o no Brasil, na Funda\u00e7\u00e3o Oswaldo Cruz (Fiocruz). At\u00e9 aqui, o que estava liberado para uso dizia respeito \u00e0s doses importadas do Instituto Serum, na \u00cdndia.\u00a0 A autoriza\u00e7\u00e3o permite que a vacina seja aplicada em pessoas acima de 18 anos.<\/p>\n<p style=\"text-align: justify;\">Trata-se do segundo ant\u00edgeno a contar com tal aprova\u00e7\u00e3o no Brasil, a primeira foi a vacina da farmac\u00eautica Pfizer \u2014 ainda n\u00e3o aplicada no pa\u00eds, uma vez que o acordo de compra entre a farmac\u00eautica e o Minist\u00e9rio da Sa\u00fade n\u00e3o foi fechado.<\/p>\n<p style=\"text-align: justify;\">Fonte: Veja<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) concedeu o registro definitivo para dois f\u00e1rmacos utilizados no combate \u00e0\u00a0Covid-19. S\u00e3o eles: a vacina de Oxford, j\u00e1 usada em car\u00e1ter emergencial e o medicamento remdesivir, da biofarmac\u00eautica americana Gilead Sciences. O antiviral tamb\u00e9m contou com autoriza\u00e7\u00e3o por parte da Food And Drug Administration (FDA), a ag\u00eancia reguladora &hellip;<\/p>\n","protected":false},"author":2,"featured_media":63150,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"facebook_2648258775420054_1618374048415101":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":"","_jetpack_memberships_contains_paid_content":false},"categories":[125],"tags":[434,10222,5711],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Anvisa d\u00e1 registro definitivo \u00e0 vacina de Oxford e autoriza o remdesivir<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anvisa d\u00e1 registro definitivo \u00e0 vacina de Oxford e autoriza o remdesivir\" \/>\n<meta property=\"og:description\" content=\"A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) concedeu o registro definitivo para dois f\u00e1rmacos utilizados no combate \u00e0\u00a0Covid-19. S\u00e3o eles: a vacina de Oxford, j\u00e1 usada em car\u00e1ter emergencial e o medicamento remdesivir, da biofarmac\u00eautica americana Gilead Sciences. O antiviral tamb\u00e9m contou com autoriza\u00e7\u00e3o por parte da Food And Drug Administration (FDA), a ag\u00eancia reguladora &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/\" \/>\n<meta property=\"og:site_name\" content=\"Portal NPM\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-12T20:59:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/BB1euBeE.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Genival Barbosa\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Genival Barbosa\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/\",\"url\":\"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/\",\"name\":\"Anvisa d\u00e1 registro definitivo \u00e0 vacina de Oxford e autoriza o remdesivir\",\"isPartOf\":{\"@id\":\"https:\/\/portalnpm.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/BB1euBeE.jpeg\",\"datePublished\":\"2021-03-12T20:59:00+00:00\",\"dateModified\":\"2021-03-12T20:59:00+00:00\",\"author\":{\"@id\":\"https:\/\/portalnpm.com\/#\/schema\/person\/49313e563cfdefcc167f1ee4c017c294\"},\"breadcrumb\":{\"@id\":\"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/#primaryimage\",\"url\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/BB1euBeE.jpeg\",\"contentUrl\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/BB1euBeE.jpeg\",\"width\":600,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/portalnpm.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anvisa d\u00e1 registro definitivo \u00e0 vacina de Oxford e autoriza o remdesivir\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/portalnpm.com\/#website\",\"url\":\"https:\/\/portalnpm.com\/\",\"name\":\"Portal NPM\",\"description\":\"Not\u00edcias em Primeira M\u00e3o\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/portalnpm.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/portalnpm.com\/#\/schema\/person\/49313e563cfdefcc167f1ee4c017c294\",\"name\":\"Genival Barbosa\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/portalnpm.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/02\/avatar_user_2_1707743258-96x96.jpeg\",\"contentUrl\":\"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/02\/avatar_user_2_1707743258-96x96.jpeg\",\"caption\":\"Genival Barbosa\"},\"url\":\"https:\/\/portalnpm.com\/index.php\/author\/genival\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anvisa d\u00e1 registro definitivo \u00e0 vacina de Oxford e autoriza o remdesivir","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/","og_locale":"pt_BR","og_type":"article","og_title":"Anvisa d\u00e1 registro definitivo \u00e0 vacina de Oxford e autoriza o remdesivir","og_description":"A Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) concedeu o registro definitivo para dois f\u00e1rmacos utilizados no combate \u00e0\u00a0Covid-19. S\u00e3o eles: a vacina de Oxford, j\u00e1 usada em car\u00e1ter emergencial e o medicamento remdesivir, da biofarmac\u00eautica americana Gilead Sciences. O antiviral tamb\u00e9m contou com autoriza\u00e7\u00e3o por parte da Food And Drug Administration (FDA), a ag\u00eancia reguladora &hellip;","og_url":"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/","og_site_name":"Portal NPM","article_published_time":"2021-03-12T20:59:00+00:00","og_image":[{"width":600,"height":450,"url":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/BB1euBeE.jpeg","type":"image\/jpeg"}],"author":"Genival Barbosa","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Genival Barbosa","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/","url":"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/","name":"Anvisa d\u00e1 registro definitivo \u00e0 vacina de Oxford e autoriza o remdesivir","isPartOf":{"@id":"https:\/\/portalnpm.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/#primaryimage"},"image":{"@id":"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/#primaryimage"},"thumbnailUrl":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/BB1euBeE.jpeg","datePublished":"2021-03-12T20:59:00+00:00","dateModified":"2021-03-12T20:59:00+00:00","author":{"@id":"https:\/\/portalnpm.com\/#\/schema\/person\/49313e563cfdefcc167f1ee4c017c294"},"breadcrumb":{"@id":"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/#primaryimage","url":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/BB1euBeE.jpeg","contentUrl":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/BB1euBeE.jpeg","width":600,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/portalnpm.com\/index.php\/2021\/03\/12\/anvisa-da-registro-definitivo-a-vacina-de-oxford-e-autoriza-o-remdesivir\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/portalnpm.com\/"},{"@type":"ListItem","position":2,"name":"Anvisa d\u00e1 registro definitivo \u00e0 vacina de Oxford e autoriza o remdesivir"}]},{"@type":"WebSite","@id":"https:\/\/portalnpm.com\/#website","url":"https:\/\/portalnpm.com\/","name":"Portal NPM","description":"Not\u00edcias em Primeira M\u00e3o","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/portalnpm.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-BR"},{"@type":"Person","@id":"https:\/\/portalnpm.com\/#\/schema\/person\/49313e563cfdefcc167f1ee4c017c294","name":"Genival Barbosa","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/portalnpm.com\/#\/schema\/person\/image\/","url":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/02\/avatar_user_2_1707743258-96x96.jpeg","contentUrl":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/02\/avatar_user_2_1707743258-96x96.jpeg","caption":"Genival Barbosa"},"url":"https:\/\/portalnpm.com\/index.php\/author\/genival\/"}]}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/portalnpm.com\/wp-content\/uploads\/2024\/01\/BB1euBeE.jpeg","_links":{"self":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/posts\/63149"}],"collection":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/comments?post=63149"}],"version-history":[{"count":0,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/posts\/63149\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/media\/63150"}],"wp:attachment":[{"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/media?parent=63149"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/categories?post=63149"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/portalnpm.com\/index.php\/wp-json\/wp\/v2\/tags?post=63149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}